• Cart

When is it safe to operate on varicose veins after superficial vein thrombosis, and can foam match heat for closing incompetent veins? In this Advanced Phlebology webinar, hosted by the Egyptian African Venous Lymphatic Association (EAVLA) with the American Venous Forum and the Journal of Vascular Surgery: Venous and Lymphatic Disorders, authors present recent research and an international panel weighs in.

What you’ll learn

  • How superficial vein thrombosis is treated in everyday practice: in the INSIGHTS-SVT study, most patients received anticoagulation and compression, with fondaparinux for 45 days as the primary option, while varicose vein surgery rose from about 2 percent at baseline to 7 percent at three months
  • Why waiting at least three months before surgery after superficial vein thrombosis lets inflammation settle, and why any urgent operation should be paired with anticoagulation
  • How polidocanol endovenous microfoam compares with thermal ablation: a network meta-analysis found no significant difference in vein closure or deep vein thrombosis risk, and higher closure odds than physician-compounded foam, with results holding from 12 months to six years
  • Perspectives from an international expert panel during discussion and audience Q&A

Agenda

  • Welcome, Dr. Ruth Bush, AVF President and Editor in Chief of JVS-VL
  • Varicose vein surgery after acute isolated superficial vein thrombosis: the INSIGHTS-SVT study, Dr. Thomas Noppeney
  • Polidocanol endovenous microfoam versus thermal ablation: a network meta-analysis, Dr. Lowell Kabnick
  • Expert discussion and Q&A

Faculty

  • Rashad Bishara (Host), President, EAVLA
  • Ruth Bush, AVF President and Editor in Chief, JVS-VL
  • Thomas Noppeney, University Hospital Regensburg, Germany
  • Lowell S. Kabnick
  • Tomasz Urbanek, Professor and Vascular Surgeon, Medical University of Silesia, Katowice, Poland
  • David Dexter
  • Willy Chi
  • Joseph Raffetto
  • Marald Wikkeling
  • Wassila Taha

Recorded live January 18, 2025. Supported by Kreussler Pharma.

AVF 2027 - Harmony in Venous Care February 27 - March 2 Grand Hyatt Nashville